Discover 1,922 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,922
Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
for
Hypertension, Type 2 Diabetes
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18 - 60
Code: NCT05168605
Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Dallas TX, Temple TX, Austin TX, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase2, Recruiting
AltaValve Early Feasibility Study Protocol
for
Mitral Regurgitation, Mitral Insufficiency,
Location: Plano TX, Oklahoma City OK, Houston TX, Houma LA,
Sponsor: 4C Medical Technologies, Inc.
Sex: All
Age: 18+
Code: NCT03997305
Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Dallas TX, Fort Worth TX, Temple TX, Austin TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase2, Recruiting
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
for
Malignant Glioma
Location: Dallas TX, Fort Worth TX, Temple TX, Austin TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 21
Code: NCT05099003
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Dallas TX, Fort Worth TX, Austin TX, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase2, Recruiting
Ketamine in Severe Traumatic Brain Injury
for
Traumatic Brain Injury, Traumatic Encephalopathy
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18+
Code: NCT06062628
Early_phase1, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Location: Dallas TX, Austin TX, Little Rock AR, Corpus Christi TX,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT07022678
Phase3, Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
for
Hypoxic-Ischemic Encephalopathy
Location: Fort Worth TX, Little Rock AR, St Louis MO,
Sponsor: ReAlta Life Sciences, Inc.
Sex: All
Age: 0
Code: NCT05778188
Phase2, Recruiting
Safety, Tolerability, PK, and Analgesic Effect of INL-001 in Children Following Open Inguinal Hernia Repair
for
Inguinal Hernia, Postoperative Pain
Location: Plano TX, Houston TX, Corpus Christi TX, El Paso TX,
Sponsor: Innocoll
Sex: All
Age: 2 - 16
Code: NCT03262688
Phase3, Recruiting
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
for
Desmoplastic Small Round Cell Tumor, Osteosarcoma,
Location: Dallas TX, Memphis TN, St Louis MO, Atlanta GA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12 - 39
Code: NCT04616560
Phase2, Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Location: Dallas TX, Fort Worth TX, Austin TX, Oklahoma City OK,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT03126916
Phase3, Recruiting
Combining a Smartphone App With Medications to Manage Heavy Drinking
for
Alcohol Use Disorder (AUD)
Location: Dallas TX, San Antonio TX, Fayetteville AR, Omaha NE,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18 - 70+
Code: NCT06303778
Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
for
Rhabdomyosarcoma
Location: Dallas TX, Austin TX, San Antonio TX, Little Rock AR,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT07466316
Phase3, Recruiting
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
for
Castration-Sensitive Prostate Carcinoma,
Location: Dallas TX, Richardson TX, Fort Worth TX,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: Male
Age: 18+
Code: NCT06931340
Phase3, Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Dallas TX, Fort Worth TX, Houston TX, Memphis TN,